81 related articles for article (PubMed ID: 26177000)
1. Synthesis and in Vivo Evaluation of [123I]Melanin-Targeted Agents.
Roberts MP; Nguyen V; Ashford ME; Berghofer P; Wyatt NA; Krause-Heuer AM; Pham TQ; Taylor SR; Hogan L; Jiang CD; Fraser BH; Lengkeek NA; Matesic L; Gregoire MC; Denoyer D; Hicks RJ; Katsifis A; Greguric I
J Med Chem; 2015 Aug; 58(15):6214-24. PubMed ID: 26177000
[TBL] [Abstract][Full Text] [Related]
2. Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.
Mier W; Kratochwil C; Hassel JC; Giesel FL; Beijer B; Babich JW; Friebe M; Eisenhut M; Enk A; Haberkorn U
J Nucl Med; 2014 Jan; 55(1):9-14. PubMed ID: 24277756
[TBL] [Abstract][Full Text] [Related]
3. [¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models.
Viallard C; Perrot Y; Boudhraa Z; Jouberton E; Miot-Noirault E; Bonnet M; Besse S; Mishellany F; Cayre A; Maigne L; Rbah-Vidal L; D'Incan M; Cachin F; Chezal JM; Degoul F
Eur J Dermatol; 2015; 25(1):29-35. PubMed ID: 25548082
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, radiolabeling and preliminary in vivo evaluation of multimodal radiotracers for PET imaging and targeted radionuclide therapy of pigmented melanoma.
Billaud EM; Maisonial-Besset A; Rbah-Vidal L; Vidal A; Besse S; Béquignat JB; Decombat C; Degoul F; Audin L; Deloye JB; Dollé F; Kuhnast B; Madelmont JC; Tarrit S; Galmier MJ; Borel M; Auzeloux P; Miot-Noirault E; Chezal JM
Eur J Med Chem; 2015 Mar; 92():818-38. PubMed ID: 25637883
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives.
Moreau MF; Papon J; Labarre P; Moins N; Borel M; Bayle M; Bouchon B; Madelmont JC
Nucl Med Biol; 2005 May; 32(4):377-84. PubMed ID: 15878507
[TBL] [Abstract][Full Text] [Related]
6. Phage display library derived peptides that bind to human tumor melanin as potential vehicles for targeted radionuclide therapy of metastatic melanoma.
Howell RC; Revskaya E; Pazo V; Nosanchuk JD; Casadevall A; Dadachova E
Bioconjug Chem; 2007; 18(6):1739-48. PubMed ID: 17907769
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, radioiodination and in vivo screening of novel potent iodinated and fluorinated radiotracers as melanoma imaging and therapeutic probes.
Maisonial A; Billaud EM; Besse S; Rbah-Vidal L; Papon J; Audin L; Bayle M; Galmier MJ; Tarrit S; Borel M; Askienazy S; Madelmont JC; Moins N; Auzeloux P; Miot-Noirault E; Chezal JM
Eur J Med Chem; 2013 May; 63():840-53. PubMed ID: 23603044
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of ¹²³/¹³¹I-Iochlonicotinamide as a novel SPECT probe for malignant melanoma.
Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
Bioorg Med Chem; 2015 May; 23(9):2261-9. PubMed ID: 25800432
[TBL] [Abstract][Full Text] [Related]
9. Anti-melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution.
Bonnet M; Mishellany F; Papon J; Cayre A; Penault-Llorca F; Madelmont JC; Miot-Noirault E; Chezal JM; Moins N
Pigment Cell Melanoma Res; 2010 Oct; 23(5):e1-11. PubMed ID: 20444199
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of a novel radioiodinated phenylacetamide and its homolog as theranostic agents for malignant melanoma.
Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
Eur J Pharm Sci; 2016 Jan; 81():201-9. PubMed ID: 26517961
[TBL] [Abstract][Full Text] [Related]
11. Preparation and biologic evaluation of a novel radioiodinated benzylpiperazine, 123I-MEL037, for malignant melanoma.
Pham TQ; Berghofer P; Liu X; Greguric I; Dikic B; Ballantyne P; Mattner F; Nguyen V; Loc'h C; Katsifis A
J Nucl Med; 2007 Aug; 48(8):1348-56. PubMed ID: 17631542
[TBL] [Abstract][Full Text] [Related]
12. Single photon emission computed tomography/positron emission tomography imaging and targeted radionuclide therapy of melanoma: new multimodal fluorinated and iodinated radiotracers.
Maisonial A; Kuhnast B; Papon J; Boisgard R; Bayle M; Vidal A; Auzeloux P; Rbah L; Bonnet-Duquennoy M; Miot-Noirault E; Galmier MJ; Borel M; Askienazy S; Dollé F; Tavitian B; Madelmont JC; Moins N; Chezal JM
J Med Chem; 2011 Apr; 54(8):2745-66. PubMed ID: 21417462
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of novel radioiodinated nicotinamides for malignant melanoma.
Liu X; Pham TQ; Berghofer P; Chapman J; Greguric I; Mitchell P; Mattner F; Loc'h C; Katsifis A
Nucl Med Biol; 2008 Oct; 35(7):769-81. PubMed ID: 18848662
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.
Joyal JL; Barrett JA; Marquis JC; Chen J; Hillier SM; Maresca KP; Boyd M; Gage K; Nimmagadda S; Kronauge JF; Friebe M; Dinkelborg L; Stubbs JB; Stabin MG; Mairs R; Pomper MG; Babich JW
Cancer Res; 2010 May; 70(10):4045-53. PubMed ID: 20442292
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, radiofluorination, and in vivo evaluation of novel fluorinated and iodinated radiotracers for PET imaging and targeted radionuclide therapy of melanoma.
Billaud EM; Rbah-Vidal L; Vidal A; Besse S; Tarrit S; Askienazy S; Maisonial A; Moins N; Madelmont JC; Miot-Noirault E; Chezal JM; Auzeloux P
J Med Chem; 2013 Nov; 56(21):8455-67. PubMed ID: 24044531
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of a iodine-125-labeled pyrrolo[1,2-a]thieno[3,2-e]pyrazine and evaluation as a potential 5-HT4R SPECT tracer.
Cailly T; Dumas N; Millet P; Lemaître S; Fabis F; Charnay Y; Rault S
Eur J Med Chem; 2010 Nov; 45(11):5465-7. PubMed ID: 20817325
[TBL] [Abstract][Full Text] [Related]
17. In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide molecule.
Degoul F; Borel M; Jacquemot N; Besse S; Communal Y; Mishellany F; Papon J; Penault-Llorca F; Donnarieix D; Doly M; Maigne L; Miot-Noirault E; Cayre A; Cluzel J; Moins N; Chezal JM; Bonnet M
Int J Cancer; 2013 Sep; 133(5):1042-53. PubMed ID: 23404099
[TBL] [Abstract][Full Text] [Related]
18. Radiation dosimetry of [
Jouberton E; Perrot Y; Dirat B; Billoux T; Auzeloux P; Cachin F; Chezal JM; Filaire M; Labarre P; Miot-Noirault E; Millardet C; Valla C; Vidal A; Degoul F; Maigne L
Med Phys; 2018 Nov; 45(11):5251-5262. PubMed ID: 30179267
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.
Chezal JM; Papon J; Labarre P; Lartigue C; Galmier MJ; Decombat C; Chavignon O; Maublant J; Teulade JC; Madelmont JC; Moins N
J Med Chem; 2008 Jun; 51(11):3133-44. PubMed ID: 18481842
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Radioiodinated Fluoronicotinamide/Fluoropicolinamide-Benzamide Derivatives as Theranostic Agents for Melanoma.
Chen CC; Chen YY; Lo YH; Lin MH; Chang CH; Chen CL; Wang HE; Wu CY
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
